A novel combination of two drugs has shown anti-cancer activity in patients who had incurable solid tumors and carried a germline mutation in their BRCA genes, Dana-Farber Cancer Institute researchers reported at the American Association for Cancer Research annual meeting in Washington, April 6-10...
More...